Scholars Central

Conference abstractPublished 1 Oct 2018

The STOMP in children and adolescents with learning disabilities in South Wales, UK

Authors: Amani Hassan, Collins Ann

Cwm Taf Health Board, UK

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Stopping Over Medication of People (STOMP) with a learning disability, autism or both is a project in the UK. It looks at people being given psychotropic medicine because their behavior is seen as challenging. People with a learning disability, autism or both are more likely to be given these medicines than other people without. These medicines can be good for some people with mental illness or challenging behavior, but have side effects such as weight gain and tiredness so the less people need this medicine, the better. Aim: Our service is a tertiary service specializing in Child and Adolescent Mental Health Service (CAMHS) Learning Disability (LD) in South Wales. It started in 2012 and covers 3 Health Boards. This project assessed how suitable the STOMP guidelines are for our patients. We also thought about how the STOMP guideline might need to change for children and adolescents. Methods: We looked at hospital notes of all 117 patients with mild to severe learning disabilities. Their age, gender, diagnosis and what medicine they were taking were written down. When patients were taking psychotropic medicine, and if we were following all of the STOMP guidelines was also recorded. If we were not doing what STOMP suggested, notes were explored to find a reason. Results: Positive Findings: (1) Clear reasons for prescribing were found in (98.39%). (2) Psycho educating patients and their families with regard to risk and benefits (95.08%). (3) Regular follow ups (96.77%). (4) Care plans considered if medication was still required (66.13%). Negative Findings: (1) Low percentage with regard to assessing capacity and gaining formal consent (11.29%). (2) The service was rated low at explaining that a medicine is ‘off-label’ (4.55%). Conclusion: CAMHS focuses their work on the whole family. Consent is gained from discussion with the family as a whole. This needs to be formalized, as STOMP recommends. Capacity assessments are only relevant for over 16 year olds. Moving forward CAMHS LD specific STOMP guidelines should be developed.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Clinical Neuropsychology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Neuropsychology: Open Access
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Amani Hassan”
  • BylineArticles whose byline prints “Collins Ann”